Antihypertensive Peptides and Their Underlying Mechanisms

Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals

Volumn , Issue , 2010, Pages 43-54

  Matsui, Toshiro ^a   Tanaka, Mitsuru ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

ACE inhibitory peptide design; Ang II stimulation; Antihypertensive peptides from natural proteins in spontaneously hypertensive rats; Antihypertensive peptides and their underlying mechanisms; Bay K 8644 stimulation; Hypertension and renin angiotensin system; Peptides, some showing vasorelaxation, antioxidative and hypocholesterolemic effects; Small peptide antihypertensive mechanism; Updated circulatory renin angiotensin system; Vascular constrictive event relaxation by dipeptides

Indexed keywords

EID: 84866417395     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813811048.ch4     Document Type: Chapter

References (53)

1. Akpaffiong MJ, Taylor AA. 1998. Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Amer J Hypertens 11: 1450-1460.
2. Bader M, Ganten D. 2008. Update on tissue renin-angiotensin systems. J Mol Med 86: 615-621.
3. Chabance B, Jolles P, Izquierdo C, Mazoyer E, Francoual C, Dronet L, Fiat AM. 1995. Characterization of antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion . Brit J Nutr 73: 583-590.
4. Dzau JV. 2001. Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis. Hypertension 37: 1047-1052.
5. Erdmann K, Grosser N, Schipporeit K, Schroder H. 2006. The ACE inhibitory dipeptide Met-Tyr diminishes free radical formation in human endothelial cells via induction of heme oxygenase-1 and ferritin. J Nutr 136: 2148-2152.
6. FitzGerald JR, Murray AB, Walsh JD. 2004. Hypotensive peptides from milk proteins. J Nutr 134: 980-988S.
7. Fujita H, Yamagami T, Ohshima K. 2001. Effects of an ACE-inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects. Nutr Res 21: 1149-1158.
8. Fujita H, Yoshikawa M. 1999. LKPNM: A prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 44: 123-127.
9. Hartmann R, Meisel H. 2007. Food-derived peptides with biological activity: From research to food applications. Curr Opin Biotechol 18: 163-169.
10. Hernandez-Ledesma B, Davalos A, Bartolome B, Amigo L. 2005. Preparation of antioxidant enzymatic hydrolysates from alpha-lactalbumin and beta-lactoglobulin. Identification of active peptides by HPLC-MS/MS. J Agric Food Chem 53: 588-593.
11. Hockerman GH, Peterson BZ, Johnson BD, Catterall WA. 1997. Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 37: 361-396.
12. Hooper NM. 1991. Angiotensin converting enzyme: Implications from molecular biology for its physiological functions. Intl J Biochem 23: 641-647.
13. Horiguchi N, Horiguchi H, Suzuki Y. 2005. Effect of wheat gluten hydrolysate on the immune system in healthy human subjects. Biosci Biotechnol Biochem 69 (12): 2445-2449.
14. Jankowski A, Skorek A, Krzysko K, Zarzycki KP, Ochocka JR, Lamparczyk H. 1995. Captopril: Determination in blood and pharmacokinetics after single oral dose. J Pharm Biomed Anal 13: 655-660.
15. Japanese Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/.
16. Kajimoto O, Nakamura Y, Yada H, Moriguchi S, Hirata H, Takahashi T. 2001. Hypotensive effects of sour milk in subjects with mild or moderate hypertension. J Jpn Soc Nutr Food Sci 54: 347-354.
17. Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H. 2007. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale for salt restriction and salt-restriction target level for the management of hypertension. Hypertens Res 30: 879-886.
18. Kawasaki T, Seki E, Osajima K, Yoshida M, Asada K, Matsui T, Osajima Y. 2000. Antihypertensive effect of Valyl-Tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens 14: 519-523.
19. 2+ channel. Mol Pharmacol 51: 262-268.
20. Matoba N, Usui H, Fujita H, Yoshikawa M. 1999. A novel antihypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett 452: 181-184.
21. Matsui T, Hayashi A, Tamaya K, Matsumoto K, Kawasaki T, Murakami K, Kimoto K. 2003. Depressor effect induced by dipeptide, Val-Tyr, in hypertensive transgenic mice is due, in part, to the suppression of human circulating renin-angiotensin system. Clin Exp Pharmacol Physiol 30: 262-265.
22. Matsui T, Imamura M, Oka H, Osajima K, Kimoto K, Kawasaki T, Matsumoto K. 2004. Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats. J Pept Sci 10: 535-545.
23. Matsui T, Matsumoto K. 2006. Antihypertensive peptides from natural resources. In: THM Khan, A Ather, eds., Lead Molecules from Natural Products: Discovery and New Trends, 255-271. Amsterdam: Elsevier.
24. Matsui T, Tamaya K, Seki E, Osajima K, Matsumoto K, Kawasaki T. 2002. Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system. Clin Exp Pharmacol Physiol 29: 204-208.
25. 2+ channel inhibition in cultured vascular smooth muscle cells. Hypertens Res 28: 545-552.
26. McCann BK, Shiell JB, Michalski PW, Lee A, Wan J, Roginski H, Coventry JM. 2006. Isolation and characterisation of a novel antibacterial peptide from bovine aS1-casein. Intl Dairy J 16: 316-323.
27. Mehta KP, Griendling KK. 2007. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Amer J Physiol-Cell Physiol 292: C82-97.
28. Meisel H. 2005. Biochemical properties of peptides encrypted in bovine milk proteins. Curr Med Chem 12: 1905-1919.
29. Miguel M, Alvarez Y, López-Fandiño R, Alonso JM, Salaices M. 2007b. Vasodilator effects of peptides derived from egg white proteins. Regul Pept 140: 131-135.
30. Miguel M, Manso AM, López-Fandiño R, Alonso JM, Salaices M. 2007a. Vascular effects and antihypertensive properties of kappa-casein macropeptide. Intl Dairy J 17: 1473-1477.
31. Millatta JL, Abdel-Rahmanb ME, Siragy MH. 1999. Angiotensin II and nitric oxide: A question of balance. Regul Pept 81: 1-10.
32. Minami H, Morse EL, Adibi SA. 1992. Characteristics and mechanism of glutamine-dipeptide absorption in human intestine. Gastroenterology 103 (1): 3-11.
33. Mine Y, Kovacs-Nolan J. 2006. New insights in biologically active proteins and peptides derived from hen egg. World's Poultry Sci J 62: 87-96.
34. Miura S, Saku K, Karnik SS. 2003. Molecular analysis of the structure and function of the angiotensin II type 1 receptor. Hypertens Res 26: 937-943.
35. Morikawa K, Ishikawa K, Kanemaru Y, Hori G, Nagaoka S. 2007. Effects of dipeptides having a C-terminal lysine on the cholesterol 7α-hydroxylase mRNA level in HepG2 cells. Biosci Biotechnol Biochem 71 (3): 821-825.
36. Nagaoka S, Futamura Y, Miwa K, Awano T, Yamauchi K, Kanamaru Y, Kojima T, Kuwata T. 2001. Identification of novel hypocholesterolemic peptides derived from bovine milk betalactoglobulin. Biochem Biophys Res Commun 281: 11-17.
37. Nakamura Y, Yamamoto N, Sakai K, Takano T. 1995. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 78: 1253-1257.
38. Okunishi T, Kawamoto Y, Kurobe Y, Oka K, Ishii K, Tanaka M, Miyazaki M. 1991. Pathogenic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 18: 649-659.
39. Ririe GD, Roberts RP, Shouse NM, Zaloga PG. 2000. Vasodilatory actions of the dietary peptide carnosine. Nutrition 16: 168-172.
40. Sealey JE, Laragh JH. 1990. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: JH Laraph, BM Brenner, eds., Hypertension: Pathophysiology, Diagnosis, and Management, 1287-1317. New York: Raven Press.
41. Sekiya S, Kobayashi Y, Kita E, Imamura Y, Toyama S. 1992. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J Jpn Soc Nutr Food Sci 45: 513-517.
42. Stepien O, Iouzalen L, Herembert T, Zhu D, Marche P. 1997. Amlodipine and vascular hypertrophy. Intl J Cardiol 62 (Suppl 2): S79-84.
43. Suzuki A, Kagawa D, Ochiai R, Tokimitsu I, Saito I. 2002. Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats. Hypertens Res 25: 99-107.
44. Takahashi M, Moriguchi S, Yoshikawa M. 1994. Isolation and characterization of oryzatensin: A novel bioactive peptide with ileum-contracting and immunomodulating activities derived from rice albumin. Biochem Mol Biol Intl 33: 1151-1158.
45. Tanaka M, Matsui T, Ushida Y, Matsumoto K. 2006. Vasodilating effect of di-peptides in thoracic aortas from spontaneously hypertensive rats. Biosci Biotechnol Biochem 70 (9): 2292-2295.
46. Tanaka M, Tokuyasu M, Matsui T, Matsumoto K. 2008. Endothelium-independent vasodilation effect of di-and tri-peptides in thoracic aorta of Sprague-Dawley rats. Life Sci 82: 869-875.
47. Tsuchida T, Masuko K, Osada H, Sato T. 2001. Effect of an aqueous extract from Mycoleptodonoides aitchisonii on human blood pressure. Jpn Pharmacol Thers 29: 899-906.
48. Vercruysse L, Morel N, Camp JV, Szust J, Smagghe G. 2008. Antihypertensive mechanism of the dipeptide Val-Tyr in rat aorta. Peptides 29: 261-267.
49. Vig SB, Stouch RT, Timoszyk KJ, Quan Y, Wall AD, Smith LR, Faria NT. 2006. Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding. J Med Chem 49: 3636-3644.
50. Walker G, Cai F, Shen P, Reynolds C, Ward B, Fone C, Honda S, Koganei M, Oda M, Reynolds E. 2006. Increased remineralization of tooth enamel by milk containing added casein phosphopeptide-amorphous calcium phosphate. J Dairy Res 73: 74-78.
51. Yamakage M, Namiki A. 2002. Calcium channels-basic aspects of their structure, function and gene encoding. Can J Anaesth 49: 151-164.
52. Yamamoto N, Maeno M, Takano T. 1999. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J Dairy Sci 82: 1388-1393.
53. Zhu K, Zhou H, Qian H. 2006. Antioxidant and free radical scavenging activities of wheat germ protein hydrolysates (WGPH) prepared with alcalase. Process Biochem 41: 1296-1302.